Results 1 to 10 of about 12,067 (234)

Hypertrophic obstructive cardiomyopathy with left ventricle outflow tract chordae insertion: Surgery or alcohol septal ablation? A case report. [PDF]

open access: yesClin Case Rep, 2023
Key Clinical Message Anomalous insertion of chordae is a rare disease that could be associated with hypertrophic obstructive cardiomyopathy (HOCM), but clinical and echocardiographic diagnoses tend to be delayed. Alcohol septal ablation has emerged as an
Hammami R   +5 more
europepmc   +2 more sources

Periprocedural, Short-Term, and Long-Term Outcomes of Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A 20-Year Single-Center Experience. [PDF]

open access: yesAnatol J Cardiol, 2022
Background: Alcohol septal ablation is recommended for hypertrophic obstructive cardiomyopathy patients who had refractory symptoms despite optimal medical treatment.
Karabulut U   +5 more
europepmc   +2 more sources

TAVI-in-TAVI in a patient after alcohol septal ablation. [PDF]

open access: yesPostepy Kardiol Interwencyjnej, 2021
Cardiovascular medicine at its beginning was dominated by surgical treatment options. The trend of the last decades is heading towards catheterization procedures.
Polaková E   +3 more
europepmc   +2 more sources

3-Dimensional Multiplanar Reconstruction With Transesophageal Echocardiography for Alcohol Septal Ablation. [PDF]

open access: yesJACC Case Rep, 2023
This study described the first experience with 3-dimensional multiplanar reconstruction transesophageal echocardiography to guide percutaneous alcohol septal ablation.
Voudris K, Lesser J, Sorajja P, Hamid N.
europepmc   +2 more sources

Sequential Alcohol Septal Ablation to Resolve LV Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement. [PDF]

open access: yesJACC Case Rep
Left ventricular outflow tract obstruction (LVOTO) is a notorious complication of transcatheter mitral valve replacement (TMVR). Computed tomography–derived simulations can predict neo-LVOTO post-TMVR, whereas alcohol septal ablation can mitigate neo ...
van den Dorpel MMP   +9 more
europepmc   +2 more sources

Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients? [PDF]

open access: yesESC Heart Fail, 2023
Percutaneous and surgical therapies for septal reduction for hypertrophic cardiomyopathy have been going head‐to‐head for the past 20 years with similar outcomes and mortality rates, although contemporary myectomy seems to materialize its superiority ...
Achim A   +5 more
europepmc   +2 more sources

Successful Percutaneous Septal Alcohol Ablation After Surgical Myectomy

open access: hybridBiomolecules & Biomedicine, 2010
Hypertrophic obstructive cardiomyopathy (HOCM) is a primary, usually familial and genetically fixed myocardial hypertrophy, with dynamic left ventricular outflow tract obstruction.
Mehmed Kulić   +6 more
doaj   +3 more sources

The efficacy and safety of alcohol septal ablation stratified by alcohol dosage for patients with hypertrophic obstructive cardiomyopathy: a systematic review and meta-analysis. [PDF]

open access: yesBMC Cardiovasc Disord
Background Alcohol septal ablation (ASA) is recommended for moderate to severe symptomatic patients with hypertrophic obstructive cardiomyopathy. The current guidelines don not recommend particular alcohol doses and the amount of alcohol injected into ...
Elshahat A   +11 more
europepmc   +2 more sources

Preemptive Alcohol Septal Ablation Prior to Valve-in-Valve Transcatheter Mitral Valve Replacement With Bioprosthetic Balloon Fracture. [PDF]

open access: yesJACC Case Rep, 2021
A 78-year-old woman with bioprosthetic mitral valve degeneration at high risk for reoperation was referred for transcatheter mitral valve replacement. We describe the use of a preemptive alcohol septal ablation pre-procedurally to minimize the risk of ...
Engel Gonzalez P   +4 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy